# Trades for 2025-09-11

## MSFT — BUY 5 @ $500.88
- **Time:** 2025-09-11T21:22:29.478458
- **Reason:**
  - Weekly Reversal: MSFT was among the 10 worst 1‑week performers (-1.37%), long.

## META — BUY 3 @ $751.18
- **Time:** 2025-09-11T21:22:33.214546
- **Reason:**
  - Rebalance: Moving up toward target weight 0.0% from current -2.3% based on baseline allocation.

## JNJ — SELL 15 @ $178.50
- **Time:** 2025-09-11T21:22:36.812190
- **Reason:**
  - Rebalance: Moving down toward target weight 0.0% from current 2.7% based on baseline allocation.

## HD — SELL 6 @ $423.26
- **Time:** 2025-09-11T21:22:40.535223
- **Reason:**
  - Weekly Reversal: HD was among the 10 best 1‑week performers (2.85%), short.

## MA — SELL 4 @ $589.15
- **Time:** 2025-09-11T21:22:44.262531
- **Reason:**
  - Rebalance: Moving down toward target weight 0.0% from current 2.4% based on baseline allocation.

## KO — SELL 38 @ $67.59
- **Time:** 2025-09-11T21:22:47.979364
- **Reason:**
  - Low Volatility: KO is in the lowest decile of 60‑day vol (0.88%).

## NKE — BUY 36 @ $74.32
- **Time:** 2025-09-11T21:22:51.628495
- **Reason:**
  - Weekly Reversal: NKE was among the 10 worst 1‑week performers (-1.35%), long.

## MCD — BUY 19 @ $308.43
- **Time:** 2025-09-11T21:22:55.231362
- **Reason:**
  - Weekly Reversal: MCD was among the 10 worst 1‑week performers (-2.70%), long.
  - Low Volatility: MCD is in the lowest decile of 60‑day vol (0.98%).

## WMT — SELL 26 @ $102.64
- **Time:** 2025-09-11T21:22:58.784851
- **Reason:**
  - Weekly Reversal: WMT was among the 10 best 1‑week performers (1.70%), short.

## COST — SELL 6 @ $964.48
- **Time:** 2025-09-11T21:23:02.310386
- **Reason:**
  - Rebalance: Moving down toward target weight 0.0% from current 5.9% based on baseline allocation.

## ABBV — SELL 12 @ $220.19
- **Time:** 2025-09-11T21:23:05.836647
- **Reason:**
  - Weekly Reversal: ABBV was among the 10 best 1‑week performers (3.39%), short.

## CRM — SELL 11 @ $246.20
- **Time:** 2025-09-11T21:23:09.382949
- **Reason:**
  - Rebalance: Moving down toward target weight 0.0% from current 2.7% based on baseline allocation.

